SureTrader Advertisement
Home > Boards > Canadian > Biotechs >

Trillium Therapeutics Inc. (TRIL)

TRIL RSS Feed
Add TRIL Price Alert      Hide Sticky   Hide Intro
Moderator: NY1972
Search This Board:
Last Post: 6/24/2016 11:25:00 AM - Followers: 32 - Board type: Free - Posts Today: 0

Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR)

Home: http://trilliumtherapeutics.com/trillium-home/default.aspx

 

Trillium Therapeutics Inc. 
2488 Dunwin Drive 
Mississauga, Ontario, 
Canada L5L 1J9 
Tel: +1 416.595.0627

 

Trillium Therapeutics is an immuno-oncology company dedicated to the discovery and development of novel and innovative cancer therapies. We have two premier pre-clinical programs, SIRPαFc and a CD200 monoclonal antibody, which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system. 

 

SEC filings:  http://www.nasdaq.com/symbol/tril/sec-filings

 

Twitter:  https://twitter.com/search?q=%24TRIL&src=ctag

 

Quote:  https://www.google.com/finance?q=NASDAQ%3ATRIL&ei=dWJkV-kHiKV5wPiX4As

 

Canadian Insider:  https://www.canadianinsider.com/company?menu_tickersearch=tr

 
Currency Converter: http://www.bankofcanada.ca/en/rates/converter.html


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Last update 6/17/2016

 

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRIL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
TRIL News: Report of Foreign Issuer (6-k) 06/07/2016 07:21:19 AM
TRIL News: Report of Foreign Issuer (6-k) 05/31/2016 07:36:22 AM
TRIL News: Report of Foreign Issuer (6-k) 05/18/2016 05:01:38 PM
TRIL News: Report of Foreign Issuer (6-k) 05/13/2016 07:12:23 AM
TRIL News: Report of Foreign Issuer (6-k) 04/21/2016 07:02:25 AM
PostSubject
#236   Save a few pounds if you buy TRIL NY1972 06/24/16 11:24:59 AM
#235   how cancer spreads in the body NY1972 06/23/16 09:46:07 AM
#234   0 shares traded at 10 AM! MMs on NY1972 06/21/16 10:04:14 AM
#233   ABBV paid $5B for Rova-T NY1972 06/13/16 10:46:53 PM
#232   Anti CD47 stimulate macrophage-mediated destruction of SCLC NY1972 06/13/16 09:50:57 PM
#231   PD1 combos NY1972 06/12/16 11:57:28 PM
#230   Alexo Therapeutics is developing novel, high-affinity SIRPa variants NY1972 06/12/16 12:14:19 AM
#229   SIRPalpha and thrombospondins NY1972 06/10/16 02:05:52 PM
#228   NKTR-214 is a CD122-biased agonist designed to stimulate NY1972 06/06/16 03:02:40 PM
#227   Hu5F9-G4: anti-drug antibodies seen in P1 NY1972 06/06/16 11:52:13 AM
#226   OX40 is one of the most-hyped cancer immunotherapy NY1972 06/06/16 11:46:13 AM
#225   Personalized cancer immunotherapy paradigm NY1972 06/05/16 02:50:09 PM
#224   Written by AF: NY1972 06/05/16 12:39:15 PM
#223   RNA-LPX triggers interferon-a (IFNa) release by plasmacytoid DCs NY1972 06/01/16 11:13:00 PM
#222   Combinations: NY1972 06/01/16 10:34:11 AM
#221   PV-10 looks pretty promising https://www.pvct.com/presentation/biopharma-asia-2016/PVCT_BioPharmaAsi jondoeuk 05/31/16 06:17:00 PM
#220   Targets NY1972 05/30/16 09:53:27 AM
#219   It will be interesting to see how haNK's jondoeuk 05/26/16 12:22:07 PM
#218   Weissman: We showed that anti-CD47 blocking antibodies synergize NY1972 05/24/16 11:01:15 PM
#217   Sievers, Eric L Indirect bought more in the public NY1972 05/23/16 11:03:41 AM
#216   PD-L1 antibody in urothelial bladder cancer NY1972 05/22/16 11:51:51 PM
#215   CD47 would be more promising if Hu5F9-G4 P1 NY1972 05/22/16 04:49:07 PM
#214   Great post why big pharma has to view super_trades 05/22/16 11:54:32 AM
#213   IT: live attenuated oral (SABIN) serotype 1 poliovirus vaccine NY1972 05/21/16 09:58:31 PM
#212   Tumoral IFN? mRNA and PD-L1 protein expression to NY1972 05/21/16 09:31:38 PM
#211   PD-L1 was detected with the highest frequency in NY1972 05/21/16 09:08:14 PM
#210   PLX3397 was well tolerated and readily crossed the NY1972 05/21/16 04:19:09 PM
#209   Here is some human data on PLX3397 http://www.ncbi.nlm.nih.gov/pubmed/26449250 jondoeuk 05/21/16 08:38:57 AM
#208   Hu5F9-G4 P1 data analysis by Dewophile: NY1972 05/20/16 10:27:25 PM
#207   CSF-1R inhibition reprograms macrophages to become antitumorigenic by NY1972 05/20/16 10:19:56 PM
#206   I have a few rules. One of which jondoeuk 05/20/16 12:22:05 PM
#205   For some reason a little bit of power jondoeuk 05/20/16 12:17:42 PM
#204   anyone here think this company could mess around bfsingle 05/19/16 12:40:12 PM
#203   No calreticulin effect? 75 mil from billionaires for NY1972 05/18/16 08:04:39 PM
#202   IDO/gemcitabine / nab-paclitaxel for the treatment of metastatic NY1972 05/18/16 06:18:38 PM
#201   ASCO URL NY1972 05/18/16 06:05:52 PM
#200   Hu5F9-G4 P1 data NY1972 05/18/16 05:47:01 PM
#199   Let see what 75 mil bought. Let ONCS NY1972 05/17/16 09:02:06 PM
#198   Explaining what the trial is.... Ha Ha Ha. jondoeuk 05/16/16 05:17:34 PM
#197   Phase I GS-5829 (a BET inhibitor) in adults NY1972 05/16/16 11:16:30 AM
#196   It's frustrating but soon enough it will erupt. ronpopeil 05/09/16 08:30:29 PM
#195   When will this stock get some recognition? $80M smallcapguru 05/09/16 07:56:09 PM
#194   Q: What will TRIL present at ASCO-2016? NY1972 05/04/16 04:12:53 PM
#193   We'll soon see jondoeuk 04/22/16 11:46:58 AM
#192   Well, I guess I lost our little side RockRat 04/20/16 03:38:10 PM
#191   Hoping results are strong. I would think they ronpopeil 04/20/16 09:28:53 AM
#190   Stanford is presenting human cd47 data at ASCO super_trades 04/20/16 09:18:31 AM
#189   Immuno-Oncology Combinations NY1972 04/18/16 09:11:41 PM
#188   This implied MTD was found earlier than expected NY1972 04/17/16 12:25:56 PM
#187   That's odd??. The info from the clinicaltrials.gov site jondoeuk 04/17/16 12:14:40 AM
PostSubject